acetylcysteine and Nervous System Disorders

acetylcysteine has been researched along with Nervous System Disorders in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19901 (12.50)18.7374
1990's1 (12.50)18.2507
2000's1 (12.50)29.6817
2010's5 (62.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alexandrov, AV; Bavarsad Shahripour, R; Harrigan, MR1
Choi, IW; Choi, YH; Dilshara, MG; Kim, GY; Lee, CM; Lee, HJ; Lee, KT1
Berk, M; Dean, O; Delhey, L; Frye, R; Kumar, N; Slattery, J; Spielholz, C1
Budziszewska, B; Filip, M; Krzyzanowska, W; Pera, J; Pomierny, B1
Deb, I; Paul, S; Poddar, R; Rajagopal, S1
Adams, J; Dave, JR; Elliott, PJ; Hale, SL; Moffett, JR; Tortella, FC; Williams, AJ1
Einhorn, LH; Loehrer, PJ; Williams, SD1
Ali, SF; Hussain, S; Slikker, W1

Reviews

2 review(s) available for acetylcysteine and Nervous System Disorders

ArticleYear
N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities.
    Brain and behavior, 2014, Volume: 4, Issue:2

    Topics: Acetylcysteine; Animals; Free Radical Scavengers; Humans; Nervous System Diseases

2014
Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review.
    Neuroscience and biobehavioral reviews, 2015, Volume: 55

    Topics: Acetylcysteine; Adolescent; Adult; Clinical Trials as Topic; Female; Humans; Male; Mental Disorders; Nervous System Diseases; Neurology; Psychiatry; Randomized Controlled Trials as Topic; Treatment Outcome; Young Adult

2015

Other Studies

6 other study(ies) available for acetylcysteine and Nervous System Disorders

ArticleYear
New compound, 5-O-isoferuloyl-2-deoxy-D-ribono-γ-lacton from Clematis mandshurica: Anti-inflammatory effects in lipopolysaccharide-stimulated BV2 microglial cells.
    International immunopharmacology, 2015, Volume: 24, Issue:1

    Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line, Transformed; Clematis; Cyclooxygenase 2; Dinoprostone; Down-Regulation; Heme Oxygenase-1; Lactones; Lipopolysaccharides; Membrane Proteins; Mice; Microglia; Nervous System Diseases; NF-E2-Related Factor 2; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Phytotherapy; Plant Roots; Proline; Reactive Oxygen Species; Ribose; Signal Transduction; Thiocarbamates

2015
N-Acetylcysteine and Ceftriaxone as Preconditioning Strategies in Focal Brain Ischemia: Influence on Glutamate Transporters Expression.
    Neurotoxicity research, 2016, Volume: 29, Issue:4

    Topics: Acetylcysteine; Analysis of Variance; Animals; Brain; Brain Edema; Brain Infarction; Ceftriaxone; Disease Models, Animal; Drug Administration Schedule; Enzyme-Linked Immunosorbent Assay; Excitatory Amino Acid Transporter 2; Gene Expression Regulation; Infarction, Middle Cerebral Artery; Male; Nervous System Diseases; Neuroprotective Agents; Rats; Rats, Wistar; RNA, Messenger

2016
Aging is associated with dimerization and inactivation of the brain-enriched tyrosine phosphatase STEP.
    Neurobiology of aging, 2016, Volume: 41

    Topics: Acetylcysteine; Aging; Animals; Antioxidants; Brain; Cells, Cultured; Enzyme Activation; Glutamates; Glutathione; Nervous System Diseases; Neuroprotection; Oxidative Stress; Protein Multimerization; Protein Tyrosine Phosphatases, Non-Receptor; Rats, Sprague-Dawley; Synaptic Transmission

2016
Delayed treatment with MLN519 reduces infarction and associated neurologic deficit caused by focal ischemic brain injury in rats via antiinflammatory mechanisms involving nuclear factor-kappaB activation, gliosis, and leukocyte infiltration.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2003, Volume: 23, Issue:1

    Topics: Acetylcysteine; Animals; Astrocytes; Brain Ischemia; Cell Movement; Cysteine Endopeptidases; Gliosis; Infarction, Middle Cerebral Artery; Inflammation Mediators; Leukocytes; Male; Multienzyme Complexes; Nerve Degeneration; Nervous System Diseases; NF-kappa B; Proteasome Endopeptidase Complex; Rats; Rats, Sprague-Dawley; Recovery of Function

2003
N-acetylcysteine and ifosfamide in the treatment of unresectable pancreatic adenocarcinoma and refractory testicular cancer.
    Seminars in oncology, 1983, Volume: 10, Issue:1 Suppl 1

    Topics: Acetylcysteine; Adenocarcinoma; Adult; Aged; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Hematologic Diseases; Hematuria; Humans; Ifosfamide; Male; Middle Aged; Nervous System Diseases; Pancreatic Neoplasms; Testicular Neoplasms

1983
Role of metallothionein and other antioxidants in scavenging superoxide radicals and their possible role in neuroprotection.
    Neurochemistry international, 1996, Volume: 29, Issue:2

    Topics: Acetylcysteine; Animals; Antioxidants; Brain Chemistry; Cysteine; Electrophoresis, Polyacrylamide Gel; Free Radical Scavengers; Glutathione; Male; Metallothionein; Mice; Mice, Inbred C57BL; Nervous System Diseases; Nitrites; Superoxides

1996